View Older Stories View More Recent Stories
-
President Trump will announce the launch of the TrumpRx website Thursday night - Axios
-
GoodRx receives HITRUST i1 certification for second consecutive year
-
60 Degrees Pharmaceuticals partners with GoodRx for ARAKODA discounts
-
Jefferies Downgrades GoodRx Holdings Inc. (GDRX) to Hold
-
GoodRx launches medication savings program at Giant Eagle pharmacies
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $2.60 at BofA Securities, Underperofrm, 'We Remain Cautious'
-
GoodRx offers Wegovy pill at $149 monthly cash price
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $3 at BofA Securities
-
GoodRx launches weight loss telemedicine service and cuts GLP-1 drug prices
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $6 at TD Cowen
-
GoodRx stock falls after CBS report on TrumpRx partnerships
-
GoodRx Holdings Inc. (GDRX) PT Raised to $4 at Goldman Sachs
-
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 1c, Beats on Revenue
-
GoodRx launches hair loss subscription service starting at $16 monthly
-
BofA on GoodRx Holdings Inc. (GDRX): 'We don’t have a strong view at this time on the potential upside/downside from TrumpRx'
-
Retail Pharmacies, Goodrx Say In Talks With Trump Administration On Trumprx Participation - Reuters
-
GoodRx Holdings, Inc. (GDRX) call put ratio 124 calls to 1 put amid share rally
-
Morgan Stanley Reiterates Equalweight Rating on GoodRx Holdings Inc. (GDRX) Amid Speculation of TrumpRx
-
GoodRx Holdings, Inc. (GDRX) Spikes After CEO Discusses Trump Conversations
-
GoodRx (GDRX) Lower on Report Trump Officials Weigh Website To Help Shop For Cheaper Drugs
-
GoodRx launches Savings Wrangler brand campaign targeting drug costs
-
Mizuho Reiterates Neutral Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings, Inc. (GDRX) call put ratio 3.4 calls to 1 put with a focus on September options
-
Increasing unusual option volume: GDRX AS ALTS OPEN XNET SHLS VIK JBS IQ SRRK SONO SQNS
-
Mizuho Reiterates Neutral Rating on GoodRx Holdings Inc. (GDRX)
-
BofA Securities Reiterates Underperform Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx partners with Novo Nordisk to offer Ozempic, Wegovy for $499 monthly
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $4.25 at UBS
-
Raymond James Downgrades GoodRx Holdings Inc. (GDRX) to Outperform
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $5 at Morgan Stanley
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $3.75 at Goldman Sachs
-
GoodRx Holdings, Inc. (GDRX) Misses Q2 EPS by 1c
-
GoodRx Holdings (GDRX) Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers
-
KeyBanc on GoodRx Holdings Inc. (GDRX): 'Attractive Valuation as We Await Continued Execution'
-
KeyBanc Reiterates Overweight Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings Inc. (GDRX) PT Lowered to $4 at BofA Securities
-
Leerink Partners Reiterates Outperform Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings, Inc. (GDRX) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY25 Revenue Guidance
-
BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
-
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi
-
GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c ; Offers Guidance
-
Increasing unusual call option volume: GDRX BBAR TH MOMO PAYO EWC CWH DV ATEC
-
Truist Securities Reiterates Hold Rating on GoodRx Holdings Inc. (GDRX)
-
GoodRx certified by HITRUST for information security
-
GoodRx Holdings, Inc. (GDRX) Appoints Christopher A. McGinnis as CFO
-
GoodRx (GDRX): Scott Wagner Joins Board of Directors
-
GoodRx Holdings, Inc. (GDRX) Announces CFO Resignation
-
GoodRx (GDRX) removed from Raymond James' Favorites list
-
Wells Fargo Reiterates Overweight Rating on GoodRx Holdings Inc. (GDRX)

